DEPOMED INC's ticker is DEPO and the CUSIP is 249908104. A total of 171 filers reported holding DEPOMED INC in Q2 2018. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $541,000 | +1.3% | 81,148 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $534,000 | -18.1% | 81,148 | 0.0% | 0.00% | -50.0% |
Q4 2017 | $652,000 | +30.7% | 81,148 | -8.4% | 0.00% | +100.0% |
Q3 2017 | $499,000 | -47.4% | 88,548 | 0.0% | 0.00% | -66.7% |
Q2 2017 | $949,000 | -10.0% | 88,548 | +5.2% | 0.00% | 0.0% |
Q1 2017 | $1,055,000 | -25.8% | 84,148 | +6.8% | 0.00% | -25.0% |
Q4 2016 | $1,421,000 | -66.4% | 78,824 | -53.7% | 0.00% | -33.3% |
Q3 2016 | $4,232,000 | +178.1% | 170,242 | +119.7% | 0.01% | +20.0% |
Q2 2016 | $1,522,000 | +2278.1% | 77,476 | +1584.3% | 0.01% | – |
Q1 2016 | $64,000 | -22.9% | 4,600 | 0.0% | 0.00% | – |
Q4 2015 | $83,000 | -4.6% | 4,600 | 0.0% | 0.00% | – |
Q3 2015 | $87,000 | -12.1% | 4,600 | 0.0% | 0.00% | – |
Q2 2015 | $99,000 | -3.9% | 4,600 | 0.0% | 0.00% | – |
Q1 2015 | $103,000 | +39.2% | 4,600 | 0.0% | 0.00% | – |
Q4 2014 | $74,000 | -51.3% | 4,600 | -54.0% | 0.00% | -100.0% |
Q3 2014 | $152,000 | +10.1% | 10,000 | 0.0% | 0.00% | – |
Q2 2014 | $138,000 | – | 10,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DELTEC ASSET MANAGEMENT LLC | 2,252,402 | $31,376,000 | 7.88% |
Healthcare Value Capital, LLC | 350,000 | $4,876,000 | 7.16% |
Senvest Management, LLC | 4,977,256 | $69,333,000 | 5.82% |
Consonance Capital Management LP | 2,756,360 | $38,396,000 | 5.81% |
Opaleye Management Inc. | 325,000 | $4,527,000 | 2.82% |
Krensavage Asset Management, LLC | 447,000 | $6,227,000 | 2.23% |
Healthcare Value Capital, LLC | 100,000 | $1,393,000 | 2.05% |
Starboard Value LP | 2,950,000 | $41,094,000 | 1.44% |
HealthInvest Partners AB | 200,000 | $2,786,000 | 1.30% |
OAK RIDGE INVESTMENTS LLC | 7,206,286 | $100,384,000 | 1.29% |